Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Histiocytosis, Langerhans-Cell × dabrafenib × Clear all

Sponsor

Conditions

Melanoma 25 Neoplasms 8 Brain Neoplasms 5 Neoplasm Metastasis 3 Skin Neoplasms 2 Glioma 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oligodendroglioma 1 Nonseminomatous germ cell tumor 1 Neurocytoma 1 Multiple Myeloma 1 Leukemia, Hairy Cell 1 Hematologic Neoplasms 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Ganglioneuroma 1 Ganglioglioma 1 Fever 1 Biliary Tract Neoplasms 1 Astrocytoma 1 Ameloblastoma 1 Adamantinoma 1

Interventions

X-Rays 4 Phantoms, Imaging 4 Magnetic Resonance Spectroscopy 4 Specimen Handling 3 Nuclear Medicine Department, Hospital 3 Biopsy 2 ulixertinib 1 tipifarnib 1 thymoglobulin 1 tazemetostat 1 selpercatinib 1 palbociclib 1 olaparib 1 larotrectinib 1 fludarabine 1 erdafitinib 1 Whole-Body Irradiation 1 Vemurafenib 1 Tacrolimus 1 Rituximab 1 Pharmacogenomic Variants 1 Mycophenolic Acid 1 Melphalan 1 Lenalidomide 1 LY3023414 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Enzyme-Linked Immunosorbent Assay 1 Deferasirox 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡